Media Release | September 18, 2012
The University of British Columbia today officially opens the new Faculty of Pharmaceutical Sciences Building, a state-of-the-art learning and research facility that will enable UBC to graduate 224 new pharmacists per year by 2015 – a 47 per cent increase – and more than double the research space for drug discovery and health care innovation.
Media Release | June 5, 2012
A drug delivery system developed through the University of British Columbia’s Neglected Global Diseases Initiative and licensed to iCo Therapeutics Inc. will receive $1.1 million from the National Research Council of Canada (NRC) for clinical development as a treatment for HIV patients.
UBC-developed formulation of leishmaniasis drug shown to be stable and effective in tropical temperatures
Media Release | December 7, 2010
A new formulation of Amphotericin B (AmB) developed by University of British Columbia researchers has been shown to be stable in tropical climates and effective in treating Visceral Leishmaniasis (VL) in mouse models.
July 16, 2010
Premier Gordon Campbell and University of British Columbia President Prof. Stephen Toope led a groundbreaking ceremony for the new Pharmaceutical Sciences Building today.
Media Release | June 17, 2010
The increasing number of incidental findings in brain imaging can be managed ethically and cost-effectively by screening study participants based on gender, age and family history, according to University of British Columbia researchers.
Media Release | May 18, 2010
Public health and international development experts at the University of British Columbia are calling for a “social offset” mechanism to set aside a portion of research funding slated for neglected tropical diseases (NTD) to address broader social determinants of disease.